BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 26446828)

  • 21. Relevant effects of beta
    Boivin-Jahns V; Jahns R; Boege F
    Front Biosci (Landmark Ed); 2018 Jun; 23(11):2146-2156. PubMed ID: 29772551
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Monoclonal anti-β1-adrenergic receptor antibodies activate G protein signaling in the absence of β-arrestin recruitment.
    Hutchings CJ; Cseke G; Osborne G; Woolard J; Zhukov A; Koglin M; Jazayeri A; Pandya-Pathak J; Langmead CJ; Hill SJ; Weir M; Marshall FH
    MAbs; 2014; 6(1):246-61. PubMed ID: 24253107
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunization with human thyrotrophin receptor peptide induces an increase in thyroid hormone in rabbits.
    Ohmori M; Endo T; Ikeda M; Onaya T
    J Endocrinol; 1992 Dec; 135(3):479-84. PubMed ID: 1362578
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Beta 1-adrenergic receptor autoantibodies mediate dilated cardiomyopathy by agonistically inducing cardiomyocyte apoptosis.
    Jane-wit D; Altuntas CZ; Johnson JM; Yong S; Wickley PJ; Clark P; Wang Q; Popović ZB; Penn MS; Damron DS; Perez DM; Tuohy VK
    Circulation; 2007 Jul; 116(4):399-410. PubMed ID: 17620508
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Peptides derived from cardiovascular G-protein-coupled receptors induce morphological cardiomyopathic changes in immunized rabbits.
    Matsui S; Fu ML; Katsuda S; Hayase M; Yamaguchi N; Teraoka K; Kurihara T; Takekoshi N; Murakami E; Hoebeke J; Hjalmarson A
    J Mol Cell Cardiol; 1997 Feb; 29(2):641-55. PubMed ID: 9140822
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nanodiscs Incorporating Native β1 Adrenergic Receptor as a Novel Approach for the Detection of Pathological Autoantibodies in Patients with Dilated Cardiomyopathy.
    Sun R; Mak S; Haschemi J; Horn P; Boege F; Luppa PB
    J Appl Lab Med; 2019 Nov; 4(3):391-403. PubMed ID: 31659076
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antiadrenergic autoimmunity in postural tachycardia syndrome.
    Fedorowski A; Li H; Yu X; Koelsch KA; Harris VM; Liles C; Murphy TA; Quadri SMS; Scofield RH; Sutton R; Melander O; Kem DC
    Europace; 2017 Jul; 19(7):1211-1219. PubMed ID: 27702852
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Detection of Autoantibodies Against the 1-Adrenergic Receptor in the Sera of Patients via the Competitive cell-Based Enzyme Linked Immunosorbent Assay].
    Shevelev AY; Kostiukevich MV; Efremov EE; Vlasik TN; Mironova NA; Zykov KA; Kashirina NM; Kuznetsova IB; Sharf TV; Mamochkina EN; Lipatova LN; Peklo MM; Rutkevich PN; Yanushevskaya EV; Rybalkin IN; Stukalova OV; Malkina TA; Belyaeva MM; Kuznetsova TV; Tkachev GA; Zinchenko LV; Gupalo EM; Agapova OY; Yureneva-Tkhorzhevskaya TV; Rvacheva AV; Sidorova MV; Sadgyan AS; Tereshchenko SN; Golitsyn SP
    Kardiologiia; 2016 Dec; 56(11):61-70. PubMed ID: 28290821
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Autoimmunity against the second extracellular loop of beta(1)-adrenergic receptors induces early afterdepolarization and decreases in K-channel density in rabbits.
    Fukuda Y; Miyoshi S; Tanimoto K; Oota K; Fujikura K; Iwata M; Baba A; Hagiwara Y; Yoshikawa T; Mitamura H; Ogawa S
    J Am Coll Cardiol; 2004 Mar; 43(6):1090-100. PubMed ID: 15028372
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The IgG3 subclass of β1-adrenergic receptor autoantibodies is an endogenous biaser of β1AR signaling.
    Mohan ML; Nagatomo Y; Saha PP; Mukherjee SD; Engelman T; Morales R; Hazen SL; Tang WHW; Naga Prasad SV
    Mol Biol Cell; 2021 Apr; 32(7):622-633. PubMed ID: 33534612
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of autoantibodies against M2 muscarinic acetylcholine receptors on rabbit atria in vivo.
    Hong CM; Zheng QS; Liu XT; Shang FJ; Wang HT; Jiang WR
    Cardiology; 2009; 112(3):180-7. PubMed ID: 18679026
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Antibodies against the second extracellular loop of beta1-adrenergic receptor induce aortic endothelial dysfunction in Wistar rat].
    Abdelkrim MA; Noireaud J; Chatagnon G; Gogny M; Desfontis JC; Mallem MY
    Ann Cardiol Angeiol (Paris); 2012 Jun; 61(3):167-72. PubMed ID: 22633471
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Targeting anti-beta-1-adrenergic receptor antibodies for dilated cardiomyopathy.
    Patel PA; Hernandez AF
    Eur J Heart Fail; 2013 Jul; 15(7):724-9. PubMed ID: 23639780
    [TBL] [Abstract][Full Text] [Related]  

  • 34. AT2R autoantibodies block angiotensin II and AT1R autoantibody-induced vasoconstriction.
    Liles C; Li H; Veitla V; Liles JT; Murphy TA; Cunningham MW; Yu X; Kem DC
    Hypertension; 2015 Oct; 66(4):830-5. PubMed ID: 26259590
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of long-term active immunization with the second extracellular loop of human β
    Montaudon E; Dubreil L; Lalanne V; Jagu B; Toumaniantz G; Thorin C; Henrion D; Desfontis JC; Martignat L; Mallem MY
    Vascul Pharmacol; 2016 Dec; 87():129-138. PubMed ID: 27620808
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Modulation of beta1-adrenoceptor activity by domain-specific antibodies and heart failure-associated autoantibodies.
    Jahns R; Boivin V; Krapf T; Wallukat G; Boege F; Lohse MJ
    J Am Coll Cardiol; 2000 Oct; 36(4):1280-7. PubMed ID: 11028484
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A pilot study on the role of autoantibody targeting the beta1-adrenergic receptor in the response to beta-blocker therapy for congestive heart failure.
    Nagatomo Y; Yoshikawa T; Kohno T; Yoshizawa A; Baba A; Anzai T; Meguro T; Satoh T; Ogawa S
    J Card Fail; 2009 Apr; 15(3):224-32. PubMed ID: 19327624
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anti-beta1-adrenergic receptor autoantibodies are potent stimulators of the ERK1/2 pathway in cardiac cells.
    Tutor AS; Penela P; Mayor F
    Cardiovasc Res; 2007 Oct; 76(1):51-60. PubMed ID: 17628514
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High prevalence of antibodies against beta 1- and beta 2-adrenoceptors in patients with primary electrical cardiac abnormalities.
    Chiale PA; Rosenbaum MB; Elizari MV; Hjalmarson A; Magnusson Y; Wallukat G; Hoebeke J
    J Am Coll Cardiol; 1995 Oct; 26(4):864-9. PubMed ID: 7560610
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Low-level tragus stimulation improves autoantibody-induced hyperadrenergic postural tachycardia syndrome in rabbits.
    Guo Y; Li H; Deng J; Zhang G; Fischer H; Stavrakis S; Yu X
    Heart Rhythm O2; 2023 Feb; 4(2):127-133. PubMed ID: 36873318
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.